Life sciences debt investor BioPharma Credit said it had agreed to be lead investor and collateral agent for a $315m loan. The definitive, senior-secured loan was made to a commercial stage, private pharmaceutical company with pro-forma annual sales of around $250m. BioPharma Credit said it would provide $194m of capital and co-investors would provide $121m. Key terms included a five-year final maturity and a high-single-digit floating coupon, it said. At 2:11pm: (LON:BPCR) Biopharma Credit Plc share price was +0.01p at 1.04p
Sign up to our
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine
Plus more useful investment content and occasional promotional offers.
UK 350 Risers and Fallers
Tweets not available.